Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil

Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis received full allocation under the country’s PDP programme, pro...

By Dhallo News · September 8, 2026 at 11:18 AM IST

Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil

Source: Economic Times - NRI

Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma an

d Bionovis received full allocation under the country’s PDP programme, providing access to around 70% of public-sector demand.

SOURCE: Economic Times - NRI

ORIGINAL REPORT: Click here

DHALLO EDITORIAL STATUS: Aggregated & reviewed

Have feedback on this article?Report error or suggestion

Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil

Read More from Business

China's Strong Trade Growth Continues, Driven By Tech Demand

German exports decline 0.8% in July, missing forecasts

ferrexpo secures $15m loan from largest shareholder

5 minutes. The news that matters.